The 10-K is out. In that they list some of the competition. I wouldn't expect any BO action till at least midway or end of phase 2 testing. If interim data is impressive they could get some nibbles. Pretty big market if it works, no doubt about it.
Now for the 10-Q and then whatever other news they may have been hanging on to.
(0)
(0)
Theratechnologies Inc. (THER) Stock Research Links